18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Status:
Terminated
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies fluorine (F)-18 16 alpha-fluoroestradiol (18F-FES) positron
emission tomography (PET)/computed tomography (CT) in imaging patients with desmoid tumors.
18F-FES binds to estrogen receptors, which are present on desmoid tumors, and gives off
radiation that may be detected by PET and CT scans. The PET/CT scan forms an image that may
show where tumor cells with estrogen receptors can be found in the body.